Cargando…
Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy
Acquired von Willebrand syndrome (AVWS) is a rare hematologic disorder characterized by quantitative or qualitative defects of von Willebrand factor (vWF), a protein crucial for normal hemostasis. AVWS has been described in association with several pathologic entities with varied mechanisms. Among t...
Autores principales: | Green, Allen, Shen, Yu-Min P., Nelson, Andrew T., Sarode, Ravi, Ibrahim, Ibrahim F., Cao, Jing, Afraz, Sajjad, Yates, Sean G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530414/ https://www.ncbi.nlm.nih.gov/pubmed/36194257 http://dx.doi.org/10.1007/s00277-022-04991-9 |
Ejemplares similares
-
Acquired von Willebrand Disease Associated with Monoclonal Gammopathy of Unknown Significance
por: Basnet, Sijan, et al.
Publicado: (2017) -
Acquired von Willebrand Syndrome in IgM Monoclonal Gammopathy as the Presentation of Lymphoplasmacytic Lymphoma
por: Wolfe, Zachary, et al.
Publicado: (2017) -
Acquired von Willebrand syndrome in monoclonal gammopathy – A scoping review on hemostatic management
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2021) -
Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy: Breaking a dangerous bond
por: Jeryczynski, Georg, et al.
Publicado: (2022) -
Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report
por: Mayne, Elizabeth Sarah, et al.
Publicado: (2018)